Emyria Ltd has released a press release.
Response to ASX Price Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Emyria
- Emyria & UWA Partner to License Novel Serotonin Therapies
- September 2024 Quarterly Activities Report and Appendix 4C
- Emyria Gains Ethics Endorsement for Psilocybin Program
- Emyria Shares Interim Success in PTSD Treatment Program
- Appendix 4E & Annual Report for the Year Ended 30 June 2024
Later from Emyria
- Emyria Secures $2.525M in Strongly Supported Placement
- Leadership Updates
- December 2024 Quarterly Activities Report and Appendix 4C
- Emyria Reports Promising 3-Month PTSD Treatment Results
- Emyria Opens New Empax Centre to Meet Demand and Payer Needs
Follow Emyria into a list and get an email when it puts out news.
Follow Emyria